SCHEMBL17972393

SCHEMBL17972393

CC[C@H]1O[C@@H](Cl)C(F)[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26487819 0.76 — —
SCHEMBL18309286 0.76 — —
SCHEMBL17972383 0.76 — —
SCHEMBL10026369 0.73 — —
SCHEMBL18510816 0.73 — —
SCHEMBL19885160 0.73 — —
SCHEMBL4765156 0.73 OGA (0.32) —
SCHEMBL16769073 0.73 OGA (0.32) —
SCHEMBL15502056 0.73 OGA (0.32) —
SCHEMBL12552328 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160220595-A1 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO DEFENSE THREAT REDUCTION AGENCY, US DOD 2016-08-04 — — US disclosed
Send feedback